215 related articles for article (PubMed ID: 28634225)
21. DDX5 promotes proliferation and tumorigenesis of non-small-cell lung cancer cells by activating β-catenin signaling pathway.
Wang Z; Luo Z; Zhou L; Li X; Jiang T; Fu E
Cancer Sci; 2015 Oct; 106(10):1303-12. PubMed ID: 26212035
[TBL] [Abstract][Full Text] [Related]
22. Cyclin D1 expression in non-small-cell lung cancers: its association with altered p53 expression, cell proliferation and clinical outcome.
Mishina T; Dosaka-Akita H; Kinoshita I; Hommura F; Morikawa T; Katoh H; Kawakami Y
Br J Cancer; 1999 Jun; 80(8):1289-95. PubMed ID: 10376986
[TBL] [Abstract][Full Text] [Related]
23. The depletion of PinX1 involved in the tumorigenesis of non-small cell lung cancer promotes cell proliferation via p15/cyclin D1 pathway.
Tian XP; Jin XH; Li M; Huang WJ; Xie D; Zhang JX
Mol Cancer; 2017 Apr; 16(1):74. PubMed ID: 28372542
[TBL] [Abstract][Full Text] [Related]
24. [Expression of AKT2, cyclin D1, and MMP-9 and their correlations to clinicopathologic features of non-small cell lung cancer].
Wang J; Miao LJ; Wu YM; Wu YJ; Wang XC
Ai Zheng; 2006 Jan; 25(1):69-72. PubMed ID: 16405753
[TBL] [Abstract][Full Text] [Related]
25. The Lineage-Defining Transcription Factors SOX2 and NKX2-1 Determine Lung Cancer Cell Fate and Shape the Tumor Immune Microenvironment.
Mollaoglu G; Jones A; Wait SJ; Mukhopadhyay A; Jeong S; Arya R; Camolotto SA; Mosbruger TL; Stubben CJ; Conley CJ; Bhutkar A; Vahrenkamp JM; Berrett KC; Cessna MH; Lane TE; Witt BL; Salama ME; Gertz J; Jones KB; Snyder EL; Oliver TG
Immunity; 2018 Oct; 49(4):764-779.e9. PubMed ID: 30332632
[TBL] [Abstract][Full Text] [Related]
26. miR-186 downregulation correlates with poor survival in lung adenocarcinoma, where it interferes with cell-cycle regulation.
Cai J; Wu J; Zhang H; Fang L; Huang Y; Yang Y; Zhu X; Li R; Li M
Cancer Res; 2013 Jan; 73(2):756-66. PubMed ID: 23204228
[TBL] [Abstract][Full Text] [Related]
27. The long non-coding RNA HNF1A-AS1 regulates proliferation and metastasis in lung adenocarcinoma.
Wu Y; Liu H; Shi X; Yao Y; Yang W; Song Y
Oncotarget; 2015 Apr; 6(11):9160-72. PubMed ID: 25863539
[TBL] [Abstract][Full Text] [Related]
28. [Cyclin D1 regulates lung cancer invasion and metastasis].
Li ZL; Shao SH; Jiao F; Yue Z; Ma Y
Sheng Li Xue Bao; 2012 Feb; 64(1):55-61. PubMed ID: 22348961
[TBL] [Abstract][Full Text] [Related]
29. [Clinical significance of cyclin Dl expression in non-small cell lung cancer].
Dworakowska D
Pneumonol Alergol Pol; 2005; 73(3):297-300. PubMed ID: 16989170
[TBL] [Abstract][Full Text] [Related]
30. The relationships between cyclin D1 expression and prognosis of non-small cell lung cancer.
Zhu J; Yu L; Zhan P; Song Y; Wang Q
Zhongguo Fei Ai Za Zhi; 2010 Aug; 13(8):803-8. PubMed ID: 20704822
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of the transcription factor FOXP3 in lung adenocarcinoma sustains malignant character by promoting G1/S transition gene CCND1.
Li Y; Li D; Yang W; Fu H; Liu Y; Li Y
Tumour Biol; 2016 Jun; 37(6):7395-404. PubMed ID: 26676638
[TBL] [Abstract][Full Text] [Related]
32. DDA1, a novel oncogene, promotes lung cancer progression through regulation of cell cycle.
Cheng L; Yang Q; Li C; Dai L; Yang Y; Wang Q; Ding Y; Zhang J; Liu L; Zhang S; Fan P; Hu X; Xiang R; Yu D; Wei Y; Deng H
J Cell Mol Med; 2017 Aug; 21(8):1532-1544. PubMed ID: 28211159
[TBL] [Abstract][Full Text] [Related]
33. Expression of cyclin D1 splice variants is differentially associated with outcome in non-small cell lung cancer patients.
Li R; An SJ; Chen ZH; Zhang GC; Zhu JQ; Nie Q; Xie Z; Guo AL; Mok TS; Wu YL
Hum Pathol; 2008 Dec; 39(12):1792-801. PubMed ID: 18715616
[TBL] [Abstract][Full Text] [Related]
34. Eukaryotic initiation factor-4E and cyclin D1 expression associated with patient survival in lung cancer.
Khoury T; Alrawi S; Ramnath N; Li Q; Grimm M; Black J; Tan D
Clin Lung Cancer; 2009 Jan; 10(1):58-66. PubMed ID: 19289374
[TBL] [Abstract][Full Text] [Related]
35. PSAT1 regulates cyclin D1 degradation and sustains proliferation of non-small cell lung cancer cells.
Yang Y; Wu J; Cai J; He Z; Yuan J; Zhu X; Li Y; Li M; Guan H
Int J Cancer; 2015 Feb; 136(4):E39-50. PubMed ID: 25142862
[TBL] [Abstract][Full Text] [Related]
36. Hsa-miR-326 targets CCND1 and inhibits non-small cell lung cancer development.
Sun C; Huang C; Li S; Yang C; Xi Y; Wang L; Zhang F; Fu Y; Li D
Oncotarget; 2016 Feb; 7(7):8341-59. PubMed ID: 26840018
[TBL] [Abstract][Full Text] [Related]
37. Downregulation of TCEAL7 expression induces CCND1 expression in non-small cell lung cancer.
Orhan C; Bulut P; Dalay N; Ersen E; Buyru N
Mol Biol Rep; 2019 Oct; 46(5):5251-5256. PubMed ID: 31321645
[TBL] [Abstract][Full Text] [Related]
38. Molecular genetic alterations in thyroid transcription factor 1-negative lung adenocarcinoma in cytology specimens: A subset with aggressive behavior and a poor prognosis.
Rodriguez EF; VandenBussche CJ; Chowsilpa S; Maleki Z
Cancer Cytopathol; 2018 Oct; 126(10):853-859. PubMed ID: 30199148
[TBL] [Abstract][Full Text] [Related]
39. Interleukin-7 up-regulates cyclin D1 via activator protein-1 to promote proliferation of cell in lung cancer.
Ming J; Jiang G; Zhang Q; Qiu X; Wang E
Cancer Immunol Immunother; 2012 Jan; 61(1):79-88. PubMed ID: 21847632
[TBL] [Abstract][Full Text] [Related]
40. KRAS and NKX2-1 Mutations in Invasive Mucinous Adenocarcinoma of the Lung.
Hwang DH; Sholl LM; Rojas-Rudilla V; Hall DL; Shivdasani P; Garcia EP; MacConaill LE; Vivero M; Hornick JL; Kuo FC; Lindeman NI; Dong F
J Thorac Oncol; 2016 Apr; 11(4):496-503. PubMed ID: 26829311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
